首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Evaluation of the transporter-mediated herb-drug interaction potential of DA-9801 a standardized dioscorea extract for diabetic neuropathy in human in vitro and rat in vivo
【2h】

Evaluation of the transporter-mediated herb-drug interaction potential of DA-9801 a standardized dioscorea extract for diabetic neuropathy in human in vitro and rat in vivo

机译:评估人和大鼠体内DA-9801(一种用于糖尿病性神经病的标准化薯os提取物)的转运蛋白介导的草药-药物相互作用潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDrug transporters play important roles in the absorption, distribution, and elimination of drugs and thereby, modulate drug efficacy and toxicity. With a growing use of poly pharmacy, concurrent administration of herbal extracts that modulate transporter activities with drugs can cause serious adverse reactions. Therefore, prediction and evaluation of drug-drug interaction potential is important in the clinic and in the drug development process. DA-9801, comprising a mixed extract of Dioscoreae rhizoma and Dioscorea nipponica Makino, is a new standardized extract currently being evaluated for diabetic peripheral neuropathy in a phase II clinical study.
机译:背景药物转运蛋白在药物的吸收,分布和消除中起着重要作用,从而调节药物的功效和毒性。随着多药店的越来越多的使用,与药物一起调节转运蛋白活性的草药提取物的同时给药会引起严重的不良反应。因此,对药物相互作用的预测和评估在临床和药物开发过程中很重要。 DA-9801包含薯Di和薯Mak的混合提取物,是目前正在II期临床研究中评估的糖尿病周围神经病变的新型标准化提取物。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号